Can we predict drug permeability class in intestinal epithelial cells using in situ live-cell ATR-FTIR spectroscopy?
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2026.346043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Nikunj D Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH, UK. Hauptthemen laut MEDLINE: Epithelial Cells, Intestinal Mucosa. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Royal Society, UKRI Medical Research Council.
Abstract (Originalsprache)
BACKGROUND: Membrane permeability plays a vital role in oral drug absorption and is one of the important reasons for attrition of promising drug candidates in early-stage drug discovery. Conventional in vitro permeability assays and metabolomics-based approaches are informative but are often destructive, labor-intensive, costly and limited to endpoint measurements. Here, we report a live-cell attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy platform for label-free, cost-effective, non-destructive monitoring of biochemical responses in Caco-2 cells following exposure to model drugs spanning multiple Biopharmaceutics Classification System (BCS) classes. RESULTS: IR spectra in the biochemical fingerprint region (1800-950 cm-1) were then analysed using principal component analysis and hierarchical clustering. Distinct spectral signatures were observed for highly permeable versus poorly permeable compounds, with discriminatory features dominated by protein (amide I/II), lipid and phosphate-associated bands. Drugs that highly permeate through membranes left a clearly different spectral trail compared to those that do not. Importantly, chemometric separation was achieved within the early hours of exposure, demonstrating the potential of live-cell ATR-FTIR spectroscopy as a rapid, low-cost and non-destructive complement to conventional permeability screening assays. SIGNIFICANCE: These findings support the use of in situ live-cell ATR-FTIR spectroscopy as a promising approach for predicting drug permeability class in intestinal epithelial cells during early drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH, UK.
- Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH, UK. Electronic address: ka_lung.chan@kcl.ac.uk.
Förderung
- The Royal Society
- UKRI Medical Research Council
Zitieren
APA
Patel, N. D., Lu, Y., Rahman, K. M., & Chan, K. L. A. (2026). Can we predict drug permeability class in intestinal epithelial cells using in situ live-cell ATR-FTIR spectroscopy?. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.346043
Vancouver
Patel ND, Lu Y, Rahman KM, Chan KLA. Can we predict drug permeability class in intestinal epithelial cells using in situ live-cell ATR-FTIR spectroscopy?. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.346043
BibTeX
@article{Patel2026,
author = {Patel, Nikunj D and Lu, Yuchen and Rahman, Khondaker Miraz and Chan, K L Andrew},
title = {Can we predict drug permeability class in intestinal epithelial cells using in situ live-cell ATR-FTIR spectroscopy?},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2026.346043}
}
EUVIMED